Quantcast
Channel: BIOtechNow » Research and Development
Browsing all 16 articles
Browse latest View live

Fireside Chat with Dr. Mikael Dolsten

Day two of the BIO CEO & Investor Conference kicked off with a Fireside Chat featuring Mikael Dolsten, MD, Phd, president, worldwide research & development from Pfizer, Inc and moderated by...

View Article



Value Drivers Under the Influence – How Licensing and Key Events Affect...

The Tuesday plenary luncheon at the 2012 BIO CEO & Investor Conference featured a panel of experts representing several perspectives on valuation. The session opened with Ben Bonifant, Senior Vice...

View Article

Five Keys to Making Biotech Flourish in China

As China positions itself as a major global player in the international biotechnology arena, it has included biotechnology as one of the seven strategic priorities for scientific and technological...

View Article

BIO 2012 Super Session Recap: Ernst & Young’s Beyond Borders

The fanfare surrounding this morning’s unveiling of Ernst & Young’s 26th annual report on the state of the biotech industry, Beyond Borders, was buoyed by positive trends outlined in the report...

View Article

Image may be NSFW.
Clik here to view.

What Will It Take for the U.S. to Maintain Leadership in the Biopharma Industry?

The biopharmaceutical industry is an important contributor to U.S. economic growth and sustainability, with more than 650,000 direct jobs (supporting a total of nearly 4 million jobs) and an economic...

View Article


Image may be NSFW.
Clik here to view.

Research: Working Together Toward Cures

Modern biomedical innovation and the discovery of new cures and therapies for devastating diseases require robust collaboration and coordination among industry, research institutions and physicians. By...

View Article

Data Exclusivity Protects Innovators and Assures Investors

Biotechnology companies must have some certainty that they can protect their investment in the development of new breakthrough therapies for a substantial period of time. This protection helps...

View Article

Image may be NSFW.
Clik here to view.

How to Survive the Patent Cliff: Eli Lilly’s CEO at the BIO CEO & Investor...

Like a number of companies, Eli Lilly is confronting a wave of patent expirations called the patent cliff. The company lost U.S. patent protection on the anti-psychotic Zyprexa in the fall of 2011 and...

View Article


The Pivotal Role the Public Market Plays in Financing R&D

Growing innovators are the heart of our industry. Biotech small businesses face a dual struggle – the daily challenge of running a growing company combined with the roadblocks intrinsic to...

View Article


Image may be NSFW.
Clik here to view.

Patents Improve Public Health: Progressive Economy Reviews TRIPS at 20 Years

Progressive Economy released a research paper examining the effect of TRIPS (Trade-Related Aspects of Intellectual Property) on global health. Here are their findings quoted from their press release:...

View Article

Wanted: Tax Policies to Support Innovation

Innovative small businesses work to advance research, development, and manufacturing of technologies to help solve economic, environmental, and societal challenges. The Coalition of Small Business...

View Article

Synthetic Biology: The Sword in the Stone to Defeat Devastating Diseases

On July 17th, 2014 the House held a hearing titled: Subcommittee on Research and Technology Hearing – Policies to Spur Innovative Medical Breakthroughs from Laboratories to Patients Witnesses Dr....

View Article

Image may be NSFW.
Clik here to view.

Upcoming Panel will Highlight The Successes of The NCATS Tech Transfer Model

On October 29, 2014 the Center for Clean Energy Innovation and the House Technology Transfer Caucus will be hosting a panel of experts to discuss NIH’s NCATS program and its impact on the tech transfer...

View Article


Image may be NSFW.
Clik here to view.

BIO Deputy General Counsel Testifies on Patent Reform

On Wednesday, March 18, BIO’s Deputy Counsel for Intellectual Property, Hans Sauer, testified in front of the U.S. Senate Judiciary Committee regarding proposed reforms to the current U.S. patent...

View Article

The International Space Station Brings Big Buzz and Big Science to BIO 2015

This year, the BIO International Convention will raise the bar, yet again, through a collaborative effort with CASIS and NASA to showcase space research at this year’s convention. CASIS, the nonprofit...

View Article


BIO Is Almost Here – What To Consider Before Entering New Therapeutic Areas

Over the past decade, the biopharmaceutical industry has witnessed a shift towards specialty care. From 2008 to 2014, FDA specialty drug approvals jumped from 33 percent to over 50 percent of all...

View Article
Browsing all 16 articles
Browse latest View live




Latest Images